診断されていない疾患に対するゲノム医学
Anastasia L Wise1, Teri A Manolio1, George A Mensah2
1National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA.
Lancet (London, England)
|August 10, 2019
まとめ
ゲノム医学は ゲノム疾患を特定することで 病気の診断を強化します このアプローチは様々な臨床環境で 患者の管理と健康結果を改善します
科学分野:
- ゲノム医学
- 臨床遺伝学
- 分子診断
背景:
- ゲノム医学は患者の診断と健康状態を改善することを目的としています
- 診断されていない病気は 重要な臨床的課題をもたらします
- 現在の診断方法は 複雑な遺伝疾患では不十分かもしれません
研究 の 目的:
- ゲノム医学が以前 診断されていなかった病気の診断に 応用されるかを研究する.
- 分子診断の改善における臨床ゲノムシーケンスの役割を強調する.
- 臨床管理におけるゲノム診断の影響を議論する.
主な方法:
- エクソームとゲノム配列解析を含む臨床ゲノム配列解析に重点を置く.
- ゲノムデータをフェノタイプ情報と統合する
- 診断の精度を高めるために複数のデータタイプを分析する.
主要な成果:
- ゲノムシーケンシングは,以前未診断の疾患の診断に役立ちます.
- ゲノムデータとフェノタイプデータを組み合わせることで 診断結果が向上します
- ゲノム診断は 臨床的管理戦略を変える可能性を秘めています
結論:
- ゲノム医学,特に配列解析は 希少疾患や未診断疾患の診断に不可欠です
- 多様なデータ型を統合することで ゲノム医学における診断能力が向上します
- ゲノムシーケンシングによる 分子診断は 患者のケアと治療結果を改善します
関連する概念動画
Genomics
39.8K
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
39.8K
Genomic Imprinting and Inheritance
36.9K
Diploid organisms inherit genetic material through chromosomes from both parents. Copies of the same gene are known as alleles. In most cases, both alleles are simultaneously expressed and allow various cellular processes to function optimally. If one of the alleles is missing or mutated, the expression of the other allele can compensate; however, this is not true for all genes.
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
36.9K
Genome Size and the Evolution of New Genes
9.0K
While every living organism has a genome of some kind (be it RNA, or DNA), there is considerable variation in the sizes of these blueprints. One major factor that impacts genome size is whether the organism is prokaryotic or eukaryotic. In prokaryotes, the genome contains little to no non-coding sequence, such that genes are tightly clustered in groups or operons sequentially along the chromosome. Conversely, the genes in eukaryotes are punctuated by long stretches of non-coding sequence.
9.0K
Microorganisms in Medicine and Therapeutics
998
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
998
Comparing Mitochondrial, Chloroplast, and Prokaryotic Genomes
15.1K
The present-day mitochondrial and chloroplast genomes have retained some of the characteristics of their ancestral prokaryotes and also have acquired new attributes during their evolution within eukaryotic cells. Like prokaryotic genomes, mitochondrial and chloroplast genomes neither bind with histone-like proteins nor show complex packaging into chromosome-like structures, as observed in eukaryotes. Unlike mitotic cell divisions observed in eukaryotic cells, mitochondria and chloroplasts...
15.1K
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K


